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ABSTRACT
Background: Pancreatic cancer is a leading cause for cancer deaths worldwide and its survival rate 
remains low. The one year- and five year-survival rate remain as low as 21% and 6-8% consecutively. Little is 
known about the survival rate of pancreatic cancer in Indonesia. This study aims to evaluate the survival rate 
of pancreatic cancer patients at Gastrointestinal Endoscopy Center, Cipto Mangunkusumo Hospital, Jakarta, 
during November 2018 to December 2018.
Method: This retrospective cohort study extracted the registry data of newly diagnosed pancreatic cancer 
patients between November 2018 to December 2018 from the Gastrointestinal Endoscopy Center, Cipto 
Mangunkusumo Hospital, Jakarta. All patients were followed since they were diagnosed to two months after 
diagnosis or 31st  December 2018 or to their date of death, whichever came first. 
Results: We found 12 newly diagnosed pancreatic cancer cases between November 2018 to December 2018. 
The mean age at diagnosis was 55 years old, with 58% male, 50% sundanese, and  75% patient come from low 
educated level. About 58% cases presented with cholangitis, and the mean bilirubin concentration at diagnosis 
was 26 mg/dL. All patient came with an obstructive jaundice symptoms, and 91% had endoscopic biliary drainage 
procedure. After 2 months of observation, we found 16% patient died due to unresolved infection.
Conclusion: There were 12 cases of pancreatic cancer, of which 16% pancreatic cancer patients died within 
2 months of follow up. Infection is the main cause of morbidity and mortality in pancreatic cancer patients.
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ABSTRAK
Latar belakang: Kanker pankreas merupakan salah satu penyebab terbanyak kematian akibat kanker di 
seluruh dunia dengan angka kesintasan yang tetap rendah. Angka kesintasan satu dan lima tahun tetap rendah 
yaitu 21% dan 6-8%. Tidak banyak yang diketahui mengenai angka kesintasan kanker pankreas di Indonesia. 
Studi ini diharapkan bisa mengevaluasi angka kesintasan kanker pankreas di Pusat Endoskopi Saluran Cerna, 
Rumah Sakit Umum Pusat Nasional Cipto Mangunkusumo, Jakarta pada November 2018 sampai December 
2018 
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Metode: Studi ini menggunakan desain kohort retrospektif dengan mengambil data register dari kasus kanker 
pankreas yang baru didiagnosis pada bulan November sampai Desember 2018 dari Pusat Endoskopi Saluran 
Cerna, Rumah Sakit Umum Pusat Nasional (RSUPN) Cipto Mangunkusumo, Jakarta. Semua pasien diikuti sejak 
mereka didiagnosis sampai dua bulan setelah diagnosis atau 31 Desember 2018 atau pada tanggal kematian 
sesuai mana yang terjadi lebih dahulu
Hasil: Studi ini menemukan 12 kasus baru kanker pankreas diantara November 2018 sampai Desember 2018. 
Rerata umur saat diagnosis adalah 55 tahun dengan 58% laki-laki, 50% suku Sunda, dan 75% pasien memiliki 
tingkat pendidikan rendah. Sekitar 58% kasus datang dengan kolangitis dan rerata konsentrasi bilirubin adalah 
26 mg/dL. Semua pasien datang dengan gejala ikterus obstruktif dan pada 91% pasien dilakukan prosedur 
drainase bilier secara endoskopis. Setelah 2 bulan, kami menemukan 16% pasien meninggal karena infeksi 
yang tidak tertangani. 
Simpulan: Terdapat 12 kasus kanker pankreas yang ditemukan. Enam belas (16) % dari semua pasien 
pankreas meninggal dalam 2 bulan tindak lanjut. Infeksi merupakan penyebab utama dari morbiditas dan 
mortalitas pada pasien kanker pancreas.
Kata kunci: kanker pankreas, kesintasan, mortalitas, kematian karena kanker
INTRODUCTION
Pancreatic cancer is a rare, highly aggressive 
malignancy with high mortality rate. It is one of the 
deadliest cancer and a leading cause of death for 
malignancy, accounting for 7% of  cancer deaths and 
the 7th  largest number of cancer death worldwide.12 
The mortality rate is reported to be 8.6 per 100,000 
populations. Despite medical advances, the one year- 
and five year-survival rate remain as low as 21% and 
6-8% consecutively.3 Even at the high-volume surgery 
centers for pancreas, the mortality rate improves but 
remains high.
The numbers of new cases detected are almost 
similar to the numbers of cancer deaths, approximately 
330,000 cases per year, because early diagnosis at 
curable stage is very difficult.2 Most cases of pancreatic 
cancer are diagnosed at advanced stage since the early 
stage are usually asymptomatic. Patients with advanced 
stage of pancreatic cancer, of which the cancer has 
metastasized to other organs, have worse survival 
rate. Some studies reported that the life expectancy 
was limited to 2.5 months with best supportive care.3 
The risk factors for pancreatic cancer include aging, 
family history of inherited disorders like malignancy, 
smoking, obesity, new onset of diabetes, pancreatitis 
and certain races.4
In Indonesia, it is estimated that pancreatic cancer 
deaths reached 0.38% of total deaths. The mortality 
rate is 3.22 per 100,000 populations based on World 
Health Ranking 2014.2 However, this data might 
be underestimated due to undiagnosed cases and 
limited data support. Until recently, there is no data 
regarding the characteristics of pancreatic cancer 
patients in Indonesia and its survival rate. This study 
aims to evaluate the survival rate of pancreatic cancer 
patients in Indonesia, represented by patients in Cipto 
Mangunkusumo Hospital, Jakarta, who came to its 
Gastrointestinal Endoscopy Center.
METHOD
This study is a retrospective cohort study performed 
in December 2018. The data was collected from medical 
records and registered data of patients in Gastrointestinal 
Endoscopy Center, Cipto Mangunkusumo Hospital, 
Jakarta. New cases of pancreatic cancer diagnosed 
during November 2018 to December 2018 were 
obtained from the Gastrointestinal Endoscopy Center 
registry. Since most cases detected were advanced 
cases of pancreatic cancer, in which the life expectancy 
is less than three months in best supportive care, we 
decided to limit the survival rate to two months. All 
patients with pancreatic cancer were followed since 
they were diagnosed to two months after diagnosis or 
31st December 2018 or to their date of death, whichever 
came first. We described patient demographics, disease 
characteristics and the length of follow up by patient 
age at diagnosis.
RESULTS
The number of new cases of pancreatic cancer 
diagnosed in Gastrointestinal Endoscopy Center, 
Cipto Mangunkusumo Hospital, Jakarta between 
November 2018 to December 2018 were 12 cases. 
During this 2-month period, 12 cases were diagnosed 
using endoscopic ultrasound (EUS) and endoscopic 
The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy80
Kaka Renaldi, Atikah Isna Fatya, Sharifah Shakinah
retrograde cholangiopancreatography (ERCP). The 
majority of cases diagnosed was advanced pancreatic 
cancer, mainly due to an infiltrative finding of the 
ERCP. From all these 12 patients, 58% were men 
with mean age at diagnosis was 55 ± 5.61 years. 
Women were younger than men, with mean age of 50 
± 7.1 years compared to 55 ± 5.6 years in men. In the 
younger age groups, the incidence of pancreatic cancer 
was mainly detected in women. The male incidence 
steadily increased with age and mostly was diagnosed 
in over than 60 years old. Of these pancreatic cancer 
patients, 50% were rural residents while the others 
were urbans The majority of ethnicity of patient was 
Sundanese (50%) and Javanese (25%). In this study, 
the mean bilirubin level at the time of diagnosis was 
26 ± 10.2 mg/dL.
Table 1. Basic characteristics of subjects
Variable n (%)
Mean age (SD) 55 (5.61)*
Mean bilirubin level (SD) 25 (10.2)*
Cholangitis 7 (58)
Gender
Male
Female
7 (58)
5 (42)
Ethnics
Sundanese
Javanese
Betawi
Melayu
6 (50)
3 (25)
2 (16)
1 (9)
Level of education
Primary
Secondary
Tertiary
9 (75)
1 (9)
2 (16)
Residential area
Urban
Rural
7 (58)
5 (42)
Insurance
National health insurance
Regional health insurance
11 (91)
1 (9)
*mean, SD
There were two patients (16%) died during follow 
up. The cause of deaths were sepsis; one case was 
related to biliary infection and the other one was related 
to pulmonary infection.
DISCUSSION
The American Cancer Society’s estimated 55,440 
new cases of pancreatic cancer in the United States 
in 2018, of which 44,330 people were predicted to 
have cancer-related deaths.5 Pancreatic cancer is the 
fourth most fatal cancer in men after lung, colorectal 
and prostate, and also the fourth most fatal cancer in 
women after breast, colorectal and lung cancer.6 Data 
from WHO showed that the incidence of pancreatic 
cancer in Indonesia is 3 cases per 100,000 population. 
These data might also be underestimated because of 
many undiagnosed cases.5
This is a descriptive study about patients who 
underwent pancreatic cancer evaluation and diagnosis 
at Gastrointestinal Endoscopy Center, Mangunkusumo 
Hospital, Jakarta, during November 2018 to December 
2018. In these two months, there was 12 newly 
diagnosed pancreatic cancer cases using either EUS 
or ERCP. Most of the cases diagnosed were advanced 
pancreatic cancer due to the infiltrative findings on 
ERCP.
Pancreatic cancer is caused by an abnormal and 
uncontrolled growth of cells within the pancreas, that 
usually asymptomatic in the early span of disease.7,8 
Most cases of pancreatic cancer are diagnosed at 
advanced stage, which might be reflected in this study. 
All patients came with obstructive jaundice, in which 
58% cases presented with cholangitis. Cholangitis is 
one of the most common complications of malignant 
bile duct obstruction and consequently the most 
common presenting condition in our patients. We found 
that 58% patients had cholangitis, therefore needed the 
urgent biliary drainage. This finding is consistent with 
Jain et al, who found that malignant cause of biliary 
obstruction is mostly due to pancreatic cancer.7
We found that the mean age at diagnosis in our study 
is younger compared to other study, such as Raju et 
al.3 The mean age of diagnosis in our study was 55 
years old, compared to Raju et al which was 70 years 
old. This might be caused by a difference of exposure 
to known or suspected risk factors related to lifestyle 
or the environment, such as smoking.5 From the age 
distribution table we can see that the highest prevalence 
of pancreatic cancer is within the 6th decade. It is 
known that the risk of pancreatic cancer is increasing 
Table 2. Frequency distribution based on age groups
Group ages (year) n (%)
41-50 2 (16)
51-60 7 (58)
61-70 3 (26)
Total 12 (100)
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by age, but we only found 3 cases in over 71 year old 
group. This might be caused by a poor survival rate 
of pancreatic cancer.
In our study, all of the patient had an endoscopic 
drainage, 10 cases (83,4%) received via ERCP, 1 
case had undergone Endoscopic Ultrasound Biliary 
Drainage with EUS-guided choledocoduodenostomy 
(EUS-CDS) and 1 case had undergone percutaneous 
transhepatic biliary drainage (PTBD). Compared to 
Jain et al study, only 55% patient in Jain et al study 
underwent endoscopic drainage, while the other 45% 
had PTBD.7 Previous studies from Zhao et al and 
Bapaye et al have discussed about the superiority of 
ERCP and EUS-BD over PTBD.9,10 Bapaye et al found 
that there was a significant difference of successful rate 
of drainage between EUS-BD and PTBD in case of 
failed cannulation with ERCP.10 This may explain the 
small number of PTBD technique done in our center. 
Unless the condition of patient is not
stable enough to undergo endoscopic procedure, 
PTBD is not a preferable option due to an increase risk 
of complication such as infection, leak, or even death.10
We found that there were two patients died during 
follow up (16%). The cause of deaths were sepsis; one 
case was related to biliary infection and the other one 
was related to pulmonary infection. Previous study 
from Torgerson, showed that the causes of morbidity 
and mortality might be related to the nature of the 
disease. Increased risk of venous thromboembolism, 
malignant biliary obstruction, and malignant gastric 
outlet obstruction, might increase risk of infection, 
which was in our study, was the main cause of death.11 
Pancreatic cancer remains as one of the deadliest 
cancer type. The Mortality/Incidence ratio is 98%, with 
overall five-year survival is only 6%. The different 
finding might be due to different time length of follow 
up. Our study only use 2-month follow up to evaluate 
the survival of the patients, while others study usually 
use a longer period to follow up.5
Survival rate of pancreatic cancer is affected by 
many factor, such as staging at the time of diagnosis, 
tumor size, presence of complication, age, sex, lifestyle 
and overall health. Further study about factors affecting 
survival rate might be needed to evaluate whether there 
was a significant difference of survival and risk factor 
between Indonesia and global data.
The limitation of his study was the short period of 
follow up, which might underestimate the fatality of 
the cancer, not known stages of diseases and lack of 
baseline data of tumor markers and biopsy.
CONCLUSION
In summary, pancreatic cancer is one of the leading 
causes of cancer deaths worldwide with reported 
high mortality rate and low short-term survival rate. 
It is very important to understand the epidemiology, 
demographics and survival of these patients in order 
to carry out better prevention and management 
of this challenging cancer. However, there is still 
limited data available regarding the demographics 
and epidemiology of this malignancy, especially in 
Indonesia. This report provides brief data regarding the 
survival, mortality rate and demographics of pancreatic 
patients in the Gastrointestinal Endoscopy Center, 
Cipto Mangunkusumo Hospital, Jakarta, the leading 
national referral hospital in the country. Future study 
with longer period of follow up is needed.
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